Coldstream Laboratories announces manager of technology transfer

Sholto Maclean takes newly created role at Kentucky firm

Coldstream Laboratories, a US provider of drug product research and manufacturing services specialising in high potency and cytotoxic parenteral products, based in Lexington, Kentucky, has named Sholto Maclean as manager of technology transfer.

In this newly created position, Maclean will work with Coldstream's pharmaceutical development team to scale up processes for sterile liquid and lyophilised drug products for manufacturing in the company's sterile facility.

Maclean has more than 20 years of experience in parenteral processing, sterile product development, lyophilisation development and aseptic manufacturing. Most recently, he was a lyophilisation/technology transfer consultant for a major pharmaceutical company. Previous roles include positions at GlaxoSmithKline and DSM Pharmaceuticals.

Coldstream Laboratories operates the only sterile pharmaceutical manufacturing facility in Kentucky.

You may also like

Manufacturing

Piramal acquires Coldstream Laboratories for US$30.65m

Kentucky based CDMO specialises in sterile liquid and freeze-dried parenterals and injectables
Manufacturing

Almac highlights SDS-PAGE approach for residual protein determination in new white paper

New white paper explores robust analytical method for residual protein detection in biocatalytic API manufacturing
Manufacturing

Reliable, high-performance pump for HPLC and UHPLC

Biotech Fluidics announce the ASI 540 – an affordable, standalone solvent delivery pump - design optimised for liquid chromatography applications
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now